Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

People with Alopecia Areata and Androgenic Alopecia have more mast cells in their scalp than healthy individuals, especially those with Alopecia Areata.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

A man's skin condition and poor diet led to a scurvy diagnosis.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

A rare genetic skin condition usually affecting males was found in a 9-year-old girl.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Apoptosis may contribute to hair loss in androgenetic alopecia.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Some African American women experience central scalp hair loss, often linked to a history of fungal scalp infection.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.